Eyenovia Announces Appointment of John Gandolfo as Chief Financial Officer

NEW YORK--(BUSINESS WIRE)--Eyenovia Inc., a clinical-stage ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class micro-therapeutics for the eye, today announced the appointment of John Gandolfo as Chief Financial Officer (CFO) effective December 18, 2017. Mr. Gandolfo has more than 30 years of experience in executive and senior management positions with high growth public and private companies, primarily in the medical devices and life

Full Story →